Novartis has suspended its cell therapy clinical trials due to patient fatalities.
The posts report that the pharmaceutical company Novartis has halted clinical trials for a cell therapy treatment. This decision follows reports of patient deaths during the study, highlighting safety concerns in advanced medical research.